In vivo distribution and tissue localization of highly purified rat lymphokine-activated killer (LAK) cells

This publication has 32 references indexed in Scilit:

• Lymphokine-activated killer cells in rats. III. A simple method for the purification of large granular lymphocytes and their rapid expansion and conversion into lymphokine-activated killer cells.
  The Journal of Experimental Medicine, 1988
• Regression of established pulmonary metastases and subcutaneous tumor mediated by the systemic administration of high-dose recombinant interleukin 2.
  The Journal of Experimental Medicine, 1985
• Therapy of disseminated murine leukemia with cyclophosphamide and immune Lyt-1+,2- T cells. Tumor eradication does not require participation of cytotoxic T cells.
  The Journal of Experimental Medicine, 1985
• Induction of natural killer cell activity of thoracic duct lymphocytes by polyinosinic-polycytidylic acid (poly(I:C)) or interferon
  Cellular Immunology, 1985
• Augmentation of organ-associated natural killer activity by biological response modifiers. Isolation and characterization of large granular lymphocytes from the liver.
  The Journal of Experimental Medicine, 1984
• Natural killer activity in the rat
  Cellular Immunology, 1984
• Successful immunotherapy of natural killer-resistant established pulmonary melanoma metastases by the intravenous adoptive transfer of syngeneic lymphocytes activated in vitro by interleukin 2.
  The Journal of Experimental Medicine, 1984
• Detection in vivo 6 hours after immunization of a mediator with possible antisuppressor activity
  European Journal of Immunology, 1983
• Cyclophosphamide-facilitated adoptive immunotherapy of an established tumor depends on elimination of tumor-induced suppressor T cells.
  The Journal of Experimental Medicine, 1982
• T-cell-derived helper factor allows in vivo induction of cytotoxic T cells in nu/nu mice
  Nature, 1980